1. Pink Sheet

Why Is Drug Pricing Higher In US? Study Takes Aim At R&D Argument

 
• By Cathy Kelly

Amgen, Biogen, Pfizer and Teva generated more than twice their global R&D budgets with higher pricing in the US compared to Western Europe and Canada, researchers at Memorial Sloan Kettering found.

PharmacyReceipt-Dollars-PillBottles_1200x675

The premium prices that biopharma manufacturers charge in the US compared to Europe and Canada often generate more “excess revenue” than companies spend on research and development, according to a study by Memorial Sloan Kettering Health Policy and Outcomes Center Director Peter Bach and researchers Nancy Yu and Zachary Helms.

The study, which was published in the Health Affairsblog March 7, challenges the argument that pricing is set higher in the US than in other countries to help...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Pricing Debate

More from Market Access

PBM Investigation, Enforcement Action ‘Critical Priorities’ At FTC, Chair Says

 
• By Cathy Kelly

The new FTC chair addressed concerns that staffing cuts will undermine the commission’s commitment to pharmacy benefit manager oversight.

US FDA’s Familiar Drug Pricing To-Do List

 
• By Michael McCaughan

President Trump’s new Executive Order on drug pricing reprises several policy themes from his first administration, including giving the FDA many tasks intended to increase competition in the marketplace.

Why Hympavzi Secured English Funding For Hemophilia B But Not Hemophilia A

 
• By Neena Brizmohun

Pfizer told the Pink Sheet it would work with the health technology assessment institute, NICE, with the hope of making Hympavzi available to patients with hemophilia A via the National Health Service.